A Phase 2 clinical trial is currently recruiting adults with relapsing types of multiple sclerosis (MS) to investigate Zenas Biopharma’s experimental therapy obexelimab as a weekly subcutaneous ...

In multiple sclerosis (MS), a person's immune system attacks the protective covering (myelin sheath) of nerve fibers in the brain and spinal cord (central nervous system). MS disease-modifying ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

What is Ocrevus for MS? Ocrevus (ocrelizumab) is an approved infusion therapy that’s indicated for adults with relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome ...

Annette M. Nash (nee Torrelli), 78 of Little Egg Harbor, NJ passed away on Monday February 3rd, 2025. Annette was born and raised in Brooklyn, NY and spent time living in Jackson, NJ and Cape ...

Click the FOLLOW button to be the first to know about this artist's upcoming lots, sold lots, exhibitions and articles Annette Hartzell is an American artist who was born in 1947. How much does an ...

Since 1999, I have been committed to assisting clients improve their quality of life. My main goal is to help clients feel supported, empowered, and motivated to make changes. Fundamental to this ...

Change is in the air, and you feel it in your bones. Your creative rhythm craves a fresh reset to spark your passion. The everyday grind has lost its spark, so why not shake it up? A simple ...

Are you truly embracing your full self in your career, or are you playing a role to meet expectations? It’s easy to get caught up in the grind, adapting to what others expect of you or following ...

Stay organized, focused, and in charge. Tackle anything from small projects to large initiatives. You may or may not be a project manager, but now you can be the boss of any project with a powerful, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...